Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers

Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers

A molecular mimicry between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and human proteins supports the possibility that autoimmunity takes place during coronavirus disease 2019 (COVID-19) contributing to tissue damage. For example, anti-phospholipid antibodies (aPL) have been repor...

Full description

Bibliographic Details
Main Authors: Maria Orietta Borghi, Mauro Bombaci, Caterina Bodio, Paola Adele Lonati, Andrea Gobbini, Mariangela Lorenzo, Erminio Torresani, Antonella Dubini, Ilaria Bulgarelli, Francesca Solari, Francesca Pregnolato, Alessandra Bandera, Andrea Gori, Gianfranco Parati, Sergio Abrignani, Renata Grifantini, Pier Luigi Meroni
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Immunology
Subjects:
anti-phospholipid antibodies
SARS-CoV-2 vaccination
autoimmunity
autoantibodies
COVID-19
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.930074/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.930074/full

Similar Items